HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zahir Amoura Selected Research

Off-Label Use

5/2022Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases.
10/2017Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zahir Amoura Research Topics

Disease

65Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2024 - 02/2003
24Erdheim-Chester Disease
01/2023 - 10/2006
20COVID-19
01/2023 - 01/2020
15Thrombosis (Thrombus)
04/2024 - 03/2011
12Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
02/2024 - 10/2004
12Autoimmune Diseases (Autoimmune Disease)
01/2024 - 12/2003
12Neoplasms (Cancer)
01/2023 - 05/2005
10Sarcoidosis (Schaumann Disease)
01/2024 - 02/2006
10Infections
11/2023 - 07/2011
10Connective Tissue Diseases (Connective Tissue Disease)
05/2022 - 11/2003
10Histiocytosis
01/2021 - 06/2008
9Inflammation (Inflammations)
12/2022 - 02/2006
8Vasculitis (Vasculitides)
01/2024 - 12/2009
8Myositis (Idiopathic Inflammatory Myopathies)
05/2015 - 05/2005
7Hemorrhage
05/2021 - 10/2007
7Lupus Nephritis
01/2020 - 08/2004
7Systemic Scleroderma (Systemic Sclerosis)
01/2018 - 05/2010
6Rheumatic Diseases (Rheumatism)
02/2024 - 11/2012
5Catatonia
10/2021 - 04/2003
5Hypergammaglobulinemia (Hyperimmunoglobulinemia)
03/2014 - 03/2010
4Cutaneous Lupus Erythematosus
01/2024 - 04/2015
4Myocarditis (Carditis)
10/2023 - 05/2006
4Paraproteinemias (Monoclonal Gammopathy)
11/2022 - 06/2010
4Critical Illness (Critically Ill)
01/2022 - 01/2020
4Interstitial Lung Diseases (Interstitial Lung Disease)
12/2020 - 09/2012
4Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
11/2020 - 02/2013
4Antisynthetase syndrome
03/2017 - 09/2012
4Congenital heart block
12/2015 - 10/2004
3Capillary Leak Syndrome
11/2022 - 10/2017
3Disease Progression
11/2022 - 01/2020
3Necrosis
11/2022 - 05/2015
3Fatigue
01/2022 - 01/2019
3Lymphopenia (Lymphocytopenia)
12/2021 - 05/2013
3Glomerulonephritis
01/2020 - 05/2016
3Neurosarcoidosis
05/2019 - 12/2016
3Thrombocytopenia (Thrombopenia)
01/2019 - 10/2004
3Fibrosis (Cirrhosis)
01/2018 - 07/2012
3Rare Diseases (Rare Disease)
01/2018 - 07/2011
3Neonatal Systemic lupus erythematosus
12/2015 - 02/2011
2Cytopenia
01/2024 - 01/2018
2Venous Thromboembolism
10/2023 - 10/2023
2Renal Insufficiency (Renal Failure)
01/2023 - 01/2021
2Obesity
12/2022 - 12/2021
2Pneumonia (Pneumonitis)
12/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

29AntibodiesIBA
10/2023 - 10/2004
22Hydroxychloroquine (Plaquenil)FDA LinkGeneric
02/2024 - 11/2003
14AutoantibodiesIBA
01/2024 - 08/2004
11Antiphospholipid AntibodiesIBA
04/2024 - 12/2003
10InterferonsIBA
01/2022 - 05/2010
9Adrenal Cortex Hormones (Corticosteroids)IBA
11/2022 - 07/2011
8Immunoglobulin G (IgG)IBA
10/2023 - 05/2008
8CytokinesIBA
10/2022 - 02/2006
7Rituximab (Mabthera)FDA Link
10/2021 - 05/2009
6Mycophenolic Acid (Cellcept)FDA LinkGeneric
05/2022 - 05/2006
5Immunoglobulin M (IgM)IBA
10/2023 - 07/2011
5EnzymesIBA
10/2023 - 09/2013
5Intravenous Immunoglobulins (IVIG)FDA Link
11/2022 - 05/2008
5Proteins (Proteins, Gene)FDA Link
05/2022 - 03/2010
5Estrogens (Estrogen)FDA Link
01/2022 - 01/2017
5Phosphotransferases (Kinase)IBA
01/2020 - 02/2016
5SteroidsIBA
01/2018 - 12/2016
5VemurafenibIBA
07/2015 - 09/2012
4Retinaldehyde (Retinal)IBA
02/2024 - 02/2005
4Monoclonal AntibodiesIBA
11/2023 - 05/2015
4GlucocorticoidsIBA
11/2023 - 11/2012
4Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2023 - 05/2013
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2022 - 05/2006
4Immunoglobulin A (IgA)IBA
05/2021 - 01/2018
4Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2011
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 02/2016
4Infliximab (Remicade)FDA Link
05/2019 - 05/2017
3belimumabIBA
12/2023 - 01/2020
3VaccinesIBA
11/2023 - 01/2021
3Interferon-alpha (Interferon Alfa)IBA
11/2023 - 10/2006
3Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
10/2023 - 09/2012
3ImmunosorbentsIBA
10/2023 - 01/2019
3Antirheumatic Agents (DMARD)IBA
11/2022 - 09/2012
3Immunosuppressive Agents (Immunosuppressants)IBA
09/2022 - 06/2017
3Interleukin-17 (Interleukin 17)IBA
01/2022 - 11/2010
3Immunoglobulins (Immunoglobulin)IBA
01/2022 - 03/2017
3AntigensIBA
01/2022 - 02/2006
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2020 - 03/2011
3Azathioprine (Imuran)FDA LinkGeneric
01/2020 - 05/2006
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2019 - 03/2014
3Antinuclear AntibodiesIBA
01/2014 - 03/2011
3Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2013 - 09/2012
2Chloroquine (Aralen)FDA LinkGeneric
02/2024 - 01/2007
2desethylchloroquineIBA
02/2024 - 11/2007
2Complement System Proteins (Complement)IBA
01/2024 - 05/2013
2CalciumIBA
10/2023 - 12/2022
2Glycoproteins (Glycoprotein)IBA
10/2023 - 10/2023
2anifrolumabIBA
01/2023 - 01/2023
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 06/2010
2Abatacept (Orencia)FDA Link
11/2022 - 01/2018
2InterleukinsIBA
11/2022 - 01/2022
2Troponin T (Troponin T1)IBA
11/2022 - 01/2021

Therapy/Procedure

31Therapeutics
02/2024 - 12/2002
6Plasma Exchange
10/2021 - 04/2003
4Critical Care (Surgical Intensive Care)
12/2022 - 01/2020
4Extracorporeal Membrane Oxygenation
01/2022 - 10/2010